Topical Products for the Aging Face - 29/06/16
Résumé |
This article focuses on nonprescription home-use topical treatment technologies for the aging face and is intended to serve as a guide for the core cosmeceutical technologies currently used and to help educate and assist the selection of topical antiaging products by the professional staff and their patients. Antiaging topical treatments for patient home use should be nonirritating, compatible with the patient skin type, effective, and complementary to surgical and minimally invasive office procedures, and aesthetically elegant. New topical antiaging technologies, formulated as monotherapy or as combinations with well-known cosmeceuticals, should present adequate clinical studies to support their selection for use.
Le texte complet de cet article est disponible en PDF.Keywords : Cosmeceuticals, Retinoids, Antioxidants, AHAs, PHAs, Anti-aging, Botanical extracts
Plan
| Mr J.P. McCook is an independent consultant specializing in skin care product development and topical delivery systems for new pharmaceutical and cosmetic products. He has more than 45 years of cosmetic and pharmaceutical product development experience with technical management positions in both the pharmaceutical and cosmetic industries as CEO and founder, Discovery Partners, LLC, COO and co-founder, Berg Phama Division of Berg, LLC, Senior Vice President and CTO, Elizabeth Arden, Inc, and Vice President, R&D, Mary Kay Cosmetics. |
|
| Conflict of Interest Statement: Mr J.P. McCook is a partner in CHL Industries, LLC, which licenses topical skin care technology based on patented compositions containing sodium copper chlorophyllin complex. This compound is mentioned in this article. |
Vol 43 - N° 3
P. 597-604 - juillet 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?

